In NSCLC, commonly tested molecular markers with therapeutic relevance include EGFR, ALK, KRAS G12C, ROS1, BRAF V600E, NTRK1/2/3, MET, RET, and ERBB2. This evidence concerns the gene ROS1 and non-small cell lung carcinoma.